Quinquennial Review of Progress in Degradation Studies and Impurity Profiling: An Instrumental Perspective Statistics

References

• Zhang, K.; Pellett, J.-D.; Narang, A.-S.; Wang, Y.-J.; Zhang, Y.-T. Reactive Impurities in Large and Small Molecule Pharmaceutical Excipients – A Review. Trends Anal. Chem. 2018, 101, 34–42. DOI: 10.1016/j.trac.2017.11.003.
   Web of Science ®Google Scholar
• Mallikarjuna, S.; Ramalingam, P.; Sriram, P. Development and Validation of Stability-Indicating RP-UPLC Method for Simultaneous Estimation of Amlodipine Besylate and Atorvastatin Calcium in Pharmaceutical Dosage Forms. J. Chromatogr. Sep. Tech. 2013, 04, 3–7. DOI: 10.4172/2157-7064.1000187.
   Google Scholar
• Ambekar, A.; Kuchekar, B.-S. Application of a Validated Stability-Indicating HPTLC Method for Simultaneous Estimation of Paracetamol and Aceclofenac and Their Impurities. J. Chromatogr. Sep. Tech. 2016, 7, 1–10. DOI: 10.4172/2157-7064.1000324.
   Google Scholar
• Siddiqui, M.-R.; Alothman, Z.-A.; Rahman, N. Analytical Techniques in Pharmaceutical Analysis: A Review. Arab. J. Chem. 2017, 10, S1409–S1421. DOI: 10.1016/j.arabjc.2013.04.016.
   Web of Science ®Google Scholar
• Patil, T.; Deshpande, A.; Deshpande, S. Critical Review on the Analytical Methods for the Estimation of Clofazimine in Bulk, Biological Fluids and Pharmaceutical Formulations. Crit. Rev. Anal. Chem. 2018, 8347, 1–11. DOI: 10.1080/10408347.2018.1451298.
   Google Scholar
• Pajander, J.; Haugshøj, K.-B.; Bjørneboe, K.; Wahlberg, P.; Rantanen, J. Foreign Matter Identification from Solid Dosage Forms. J. Pharm. Biomed. Anal. 2013, 80, 116–125. DOI: 10.1016/j.jpba.2013.02.036.
   PubMed Web of Science ®Google Scholar
• Jain, A.; Sharma, S. Recent Trends in Impurity Profiling of Pharmaceutical Products. MIT Int. J. Pharm. Sci. 2017, 3, 1–6.
   Google Scholar
• Li, N.; Yang, J.; Qin, F.; Li, F.; Gong, P. Isolation and Identification of a Major Impurity in a New Bulk Drug Candidate by Preparative LC, ESI-MSn, LC-MS-MS, and NMR. Chromatogr. J. Sci. 2007, 45, 45–49. DOI: 10.1093/chromsci/45.1.45.
   PubMed Web of Science ®Google Scholar
• Roberts, J.-K.; Smith, R.-J. Use of Liquid Chromatography-Nuclear Magnetic Resonance Spectroscopy for the Identiffication of Impurities in Drug Substances. Chromatogr. J. A 1994, 677, 385–389. DOI: 10.1016/0021-9673(94)80166-5.
   Web of Science ®Google Scholar
• International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), Impurities in New Drug Substances Q3A (R2), 2006, 15.
   Google Scholar
• International Conference on Harmonisation, Q3B (R2): Impurities in New Drug Products. ICH Harmonised Tripartite Guideline. 2006, 4, 1–12.
   Google Scholar
• International Conference on Harmonisation, Q3C (R6): Impurities: Guideline for Residual Solvents. ICH Harmonised Guideline. 2016, 4, 1–34.
   Google Scholar
• International Conference on Harmonisation, Q3D, Guideline for Elemental Impurities. ICH Harmonised Tripartite Guideline. 2014, 4, 1–73.
   Google Scholar
• Singh, S.; Handa, T.; Narayanam, M.; Sahu, A.; Junwal, M.; Shah, R.-P. A Critical Review on the Use of Modern Sophisticated Hyphenated Tools in the Characterization of Impurities and Degradation Products. J. Pharm. Biomed. Anal. 2012, 69, 148–173. DOI: 10.1016/j.jpba.2012.03.044.
   PubMed Web of Science ®Google Scholar
• Guidance for Industry, Genotoxic and Carcinogenic, Impurities in Drug Substances and Products: Recommended Approaches, Draft guidance, FDA CDER. 2008, 1, 1–13.
   Google Scholar
• Kang, S.-H.; Kwon, J.-Y.; Lee, J.-K.; Seo, Y.-R. Recent Advances in in Vivo Genotoxicity Testing: prediction of Carcinogenic Potential Using Comet and Micronucleus Assay in Animal Models. J. Cancer Prev. 2013, 18, 277–288. DOI: 10.15430/JCP.2013.18.4.277.
   PubMedGoogle Scholar
• Li, N.; Yang, J.; Qin, F.; Li, F.; Gong, P. Isolation and Identification of a Major Impurity in a New Bulk Drug Candidate by Preparative LC, ESI-MSn, LC-MS-MS, and NMR. J. Chromatogr. Sci. 2007, 45, 45–49. DOI: 10.1093/chromsci/45.1.45.
   PubMed Web of Science ®Google Scholar
• Gupta, K. Analytical Quality by Design: A Mini Review. Biomed. J. Sci. Tech. Res. 2017, 1, 1–5. DOI: 10.26717/BJSTR.2017.01.000484.
   Google Scholar
• Patil, T.; Deshpande, A. Development of an Innovative Quality by Design (QbD) Based Stability-Indicating HPLC Method and Its Validation for Clofazimine from Its Bulk and Pharmaceutical Dosage Forms. Chromatographia. 2018, 82, 1–12. DOI: 10.1007/s10337-018-3660-8.
   Google Scholar
• Jain, D.; Basniwal, P.-K. Forced Degradation and Impurity Profiling: Recent Trends in Analytical Perspectives. J. Pharm. Biomed. Anal. 2013, 86, 11–35. DOI: 10.1016/j.jpba.2013.07.013.
   PubMed Web of Science ®Google Scholar
• Kurmi, M.; Singh, S. Stability Behavior of Antiretroviral Drugs and Their Combinations. 7: Comparative Degradation Pathways of Lamivudine and Emtricitabine and Explanation to Their Differential Degradation Behavior by Density Functional Theory. J. Pharm. Biomed. Anal 2017, 142, 155–161. DOI: 10.1016/j.jpba.2017.04.034.
   PubMed Web of Science ®Google Scholar
• Zhu, B.; Lu, Y.; Chen, L.; Yu, B.; Liu, Y.; Song, M.; Hang, T. Identification and Characterization of Related Substances in EVT-401 by Hyphenated LC–MS Techniques. J. Pharm. Anal, 2017, 7, 7223–7230. DOI: 10.1016/j.jpha.2017.03.008.
   Web of Science ®Google Scholar
• Kumar, N.; Devineni, S.-R.; Gajjala, P.-S.; Dubey, S.-K.; Kumar, P. Synthesis, Isolation, Identification and Characterization of New Process-Related Impurity in Isoproterenol Hydrochloride by HPLC, LC/ESI-MS and NMR. J. Pharm. Anal. 2017, 7, 394–400. DOI: 10.1016/j.jpha.2017.05.002.
   PubMed Web of Science ®Google Scholar
• Raju, C. K.; Pandey, A. K.; S, G.; Ghosh, K.; Pola, A.; Goud P, S. K.; Jaywant, M. A.; Navalgund, S. G. Isolation and Characterization of Novel Degradation Products of Doxofylline Using HPLC, FTIR, LCMS and NMR. J. Pharm. Biomed. Anal. 2017, 140, 1–10. DOI: 10.1016/j.jpba.2017.02.044.
   PubMed Web of Science ®Google Scholar
• Ruggenthaler, M.; Grass, J.; Schuh, W.; Huber, C.-G.; Reischl, R.-J. Levothyroxine Sodium Revisited: A Wholistic Structural Elucidation Approach of New Impurities via HPLC-HRMS/MS, on-Line H/D Exchange, NMR Spectroscopy and Chemical Synthesis. J. Pharm. Biomed. Anal. 2017, 135, 140–152. DOI: 10.1016/j.jpba.2016.12.002.
   PubMed Web of Science ®Google Scholar
• Gómez-Canela, C.; Bolivar-Subirats, G.; Tauler, R.; Lacorte, S. Powerful Combination of Analytical and Chemometric Methods for the Photodegradation of 5-Fluorouracil. J. Pharm. Biomed. Anal. 2017, 137, 33–41. DOI: 10.1016/j.jpba.2017.01.019.
   PubMed Web of Science ®Google Scholar
• Kumar, N.; Devineni, S.-R.; Dubey, S.-R.; Kumar, P. Potential Impurities of Anxiolytic Drug, Clobazam: Identification, Synthesis and Characterization Using HPLC, LC-ESI/MSn and NMR. J. Pharm. Biomed. Anal. 2017, 137, 268–278. DOI: 10.1016/j.jpba.2017.01.051.
   PubMed Web of Science ®Google Scholar
• Xia, K.; Shen, S.-S.; Gao, Q.; Shang, W.; Pan, Y.; Wu, J. Identification of a Novel Low-Level Impurity in Fungicide Pyraclostrobin by High-Performance Liquid Chromatography/Tandem Mass Spectrometry. J. Pharm. Biomed. Anal. 2017, 138, 272–276. DOI: 10.1016/j.jpba.2017.02.027.
   PubMed Web of Science ®Google Scholar
• Zhu, P.; Lu, J.; Hong, L.; Su, W.; Van Schepdael, A.; Adams, E. Characterization of an Unknown Impurity in Doxofylline Using LC–MS and NMR. J. Pharm. Biomed. Anal. 2017, 140, 31–37. DOI: 10.1016/j.jpba.2017.03.025.
   PubMed Web of Science ®Google Scholar
• Yu, X.; Wang, F.; Li, J.; Shan, W.; Zhu, B.; Wang, J. Separation and Characterization of Unknown Impurities and Isomers in Flomoxef Sodium by LC-IT-TOF MS and Study of Their Negative-Ion Fragmentation Regularities. J. Pharm. Biomed. Anal. 2017, 140, 81–90. DOI: 10.1016/j.jpba.2017.03.032.
   PubMed Web of Science ®Google Scholar
• Lu, Y.; Shen, X.; Hang, T.; Song, M. Identification and Characterization of Process-Related Substances and Degradation Products in Apremilast: Process Optimization and Degradation Pathway Elucidation. J. Pharm. Biomed. Anal. 2017, 141, 70–78. DOI: 10.1016/j.jpba.2017.03.067.
   PubMed Web of Science ®Google Scholar
• Zhao, L.; Wang, Q.; Bie, Y.; Lu, X. Isolation, Identification and Characterization of Potential Impurities of Anidulafungin. J. Pharm. Biomed. Anal. 2017, 141, 192–199. DOI: 10.1016/j.jpba.2017.04.014.
   PubMed Web of Science ®Google Scholar
• Ruggenthaler, M.; Grass, J.; Schuh, W.; Huber, C.-G.; Reischl, R.-J. Impurity Profiling of liothyronine sodium by Means of Reversed Phase HPLC, High Resolution Mass Spectrometry, on-Line H/D Exchange and UV/Vis Absorption. J. Pharm. Biomed. Anal. 2017, 143, 147–158. DOI: 10.1016/j.jpba.2017.05.039.
   PubMed Web of Science ®Google Scholar
• Hu, Z.; Gao, S.; Gao, J. Investigation and Structural Elucidation of a New Impurity in Bulk Drug of Cilostazol by LC/MS/MS, FT-IR and NMR. J. Pharm. Biomed. Anal. 2017, 145, 16–23. DOI: 10.1016/j.jpba.2017.06.019.
   PubMed Web of Science ®Google Scholar
• Chahrour, O.; Malone, J.; Collins, M.; Salmon, V.; Greenan, C.; Bombardier, A.; Ma, Z.; Dunwoody, N. Development and Validation of an ICP-MS Method for the Determination of Elemental Impurities in TP-6076 Active Pharmaceutical Ingredient (API) according to USP 〈232〉/〈233〉. J. Pharm. Biomed. Anal. 2017, 145, 84–90. DOI: 10.1016/j.jpba.2017.06.045.
   PubMed Web of Science ®Google Scholar
• Zhang, X.; Li, J.; Wang, C.; Song, D.; Hu, C. Identification of Impurities in Macrolides by Liquid Chromatography–Mass Spectrometric Detection and Prediction of Retention Times of Impurities by Constructing Quantitative Structure–Retention Relationship (QSRR). J. Pharm. Biomed. Anal. 2017, 145, 262–272. DOI: 10.1016/j.jpba.2017.06.069.
   PubMed Web of Science ®Google Scholar
• Zhu, P.; Lu, J.; Wang, Z.; Su, W.; Chen, Y.; Schepdael, A.-V.; Adams, E. Characterization of Impurities in Sodium Cromoglycate Drug Substance and Eye Drops Using LC-ESI-Ion Trap MS and LC-ESI-QTOF MS. J. Pharm. Biomed. Anal. 2017, 145, 537–548. DOI: 10.1016/j.jpba.2017.07.015.
   PubMed Web of Science ®Google Scholar
• Xu, Y.; Wang, D.; Tang, L.; Wang, J. Separation and Characterization of Allergic Polymerized Impurities in Cephalosporins by 2D-HPSEC × LC-IT-TOF MS. J. Pharm. Biomed. Anal. 2017, 145, 742–750. DOI: 10.1016/j.jpba.2017.07.063.
   PubMed Web of Science ®Google Scholar
• Kurmi, M.; Sahu, A.; Singh, S. Stability Behaviour of Antiretroviral Drugs and Their Combinations. 5: Characterization of Novel Degradation Products of Abacavir Sulfate by Mass and Nuclear Magnetic Resonance Spectrometry. J. Pharm. Biomed. Anal. 2017, 134, 372–384. DOI: 10.1016/j.jpba.2016.10.019.
   PubMed Web of Science ®Google Scholar
• Raju, C.-K.; Pandey, A.-K.; Ghosh, K.; Pola, A.; Goud, S.-K.; Jaywant, M.-A.; Navalgund, S.-G.; Surendranath, K.-V. Isolation and Structural Characterization of Novel Photolytic Degradation Impurities of Deflazacort Using Q-TOF, 2D-NMR and FTIR. J. Pharm. Biomed. Anal. 2017, 133, 82–89. DOI: 10.1016/j.jpba.2016.11.005.
   PubMed Web of Science ®Google Scholar
• Vishnuvardhan, C.; Saibaba, B.; Allakonda, L.; Swain, D.; Gananadhamu, S.; Srinivas, R.; Satheeshkumar, N. LC–ESI–MS/MS Evaluation of Forced Degradation Behaviour of Silodosin: In Vitro anti Cancer Activity Evaluation of Silodosin and Major Degradation Products. J. Pharm. Biomed. Anal. 2017, 134, 1–10. DOI: 10.1016/j.jpba.2016.11.013.
   PubMed Web of Science ®Google Scholar
• Darcsi, A.; Rácz, A.; Béni, S. Identification and Characterization of a New Dapoxetine Impurity by NMR: Transformation of N-Oxide by Cope Elimination. J. Pharm. Biomed. Anal. 2017, 134, 187–194. DOI: 10.1016/j.jpba.2016.11.029.
   PubMed Web of Science ®Google Scholar
• Wu, X.; Zeng, X.; Wang, L.; Hang, T.; Song, M. Identification of Related Substances in Tofacitinib Citrate by LC-MS Techniques for Synthetic Process Optimization. J. Pharm. Biomed. Anal. 2017, 143, 17–25. DOI: 10.1016/j.jpba.2017.05.012.
   PubMed Web of Science ®Google Scholar
• Martano, C.; Ferretti, F.; Ghiani, S.; Buonsanti, F.; Bruno, E.; Lattuada, L.; Medana, C. Development and Validation of a New HPLC–MS Method for Meglumine Impurity Profiling. J. Pharm. Biomed. Anal. 2018, 149, 517–524. DOI: 10.1016/j.jpba.2017.11.039.
   PubMed Web of Science ®Google Scholar
• Pasquini, B.; Melani, F.; Caprini, C.; Del Bubba, M.; Pinzauti, S.; Orlandini, S.; Furlanetto, S. Combined Approach Using Capillary Electrophoresis, NMR and Molecular Modeling for Ambrisentan Related Substances Analysis: Investigation of Intermolecular Affinities, Complexation and Separation Mechanism. J. Pharm. Biomed. Anal. 2017, 144, 220–229. DOI: 10.1016/j.jpba.2017.01.038.
   PubMed Web of Science ®Google Scholar
• Assaf, J.; Gomes, D.-Z.; Wuest, B.; Parr, M.-K. Photostability Testing Using Online Reactor HPLC Hyphenation and Mass Spectrometric Compound Identification Illustrated by Ketoprofen as Model Compound. J. Pharm. Biomed. Anal. 2017, 145, 414–422. DOI: 10.1016/j.jpba.2017.07.006.
   PubMed Web of Science ®Google Scholar
• Wahl, O.; Cleynhens, J.; Verbruggen, A.-M.; Holzgrabe, U. Impurity Profiling of N,N′-ethylenebis-L-Cysteine Diethyl Ester (Bicisate). J. Pharm. Biomed. Anal. 2018, 150, 132–136. DOI: 10.1016/j.jpba.2017.11.078.
   PubMed Web of Science ®Google Scholar
• Yang, Y.; Lian, Y.; Zhong, P.; Wang, D.; Di, B.; Li, B. Characterization and Quantitative Analysis of Related Substances in Coenzyme a by HPLC and LC–MS/MS. J. Pharm. Biomed. Anal. 2018, 150, 220–232. DOI: 10.1016/j.jpba.2017.11.051.
   PubMed Web of Science ®Google Scholar
• Huang, Z.; Hu, Y.; Zha, Y.; Perrone, R.; Ruan, J.; Fish, W.-P. Determination of Polymeric Impurities in Asunaprevir Drug Substance and Product Using Size Exclusion Effect of Reversed-Phase Columns. J. Pharm. Biomed. Anal. 2018, 151, 200–208. DOI: 10.1016/j.jpba.2018.01.018.
   PubMed Web of Science ®Google Scholar
• Zhuang, T.; Zhang, W.; Cao, L.; He, K.; Wang, Y.; Li, J.; Chen, L.; Liu, B.; Zhang, G. Isolation, Identification and Characterization of Two Novel Process-Related Impurities in Olanzapine. J. Pharm. Biomed. Anal. 2018, 152, 188–196. DOI: 10.1016/j.jpba.2018.01.026.
   PubMed Web of Science ®Google Scholar
• Kurmi, M.; Patel, N.; Jhajra, S.; Bharatam, P.-V.; Singh, S. Characterization of Forced Degradation Products of Torasemide through MS Tools and Explanation of Unusual Losses Observed during Mass Fragmentation of Drug and Degradation Products through Density Functional Theory. J. Pharm. Biomed. Anal. 2017, 145, 209–218. DOI: 10.1016/j.jpba.2017.06.015.
   PubMed Web of Science ®Google Scholar
• Karpiuk, I.; Michalska, K.; Bus, K.; Kiljan, M.; Tyski, S. Identification and Determination of Related Substances of Ceftaroline Fosamil in Medicinal Product by High Performance Liquid Chromatography with Diode Array Detection and Tandem Mass Spectrometry. J. Pharm. Biomed. Anal. 2017, 145, 651–660. DOI: 10.1016/j.jpba.2017.07.060.
   PubMed Web of Science ®Google Scholar
• Bellur Atici, E.; Yazar, Y.; Ağtaş, C.; Ridvanoğlu, N.; Karlığa, B. Development and Validation of Stability Indicating HPLC Methods for Related Substances and Assay Analyses of Amoxicillin and Potassium Clavulanate Mixtures. J. Pharm. Biomed. Anal. 2017, 136, 1–9. DOI: 10.1016/j.jpba.2016.12.032.
   PubMed Web of Science ®Google Scholar
• Vijayabaskar, S.; Mahalingam, V. Kalaivani, Analytical Method Development and Validation for the Analysis of Verapamil Hydrochloride and Its Related Substances by Using Ultra Perfomance Liquid Chromatography. J. Pharm. Biomed. Anal. 2017, 137, 189–195. DOI: 10.1016/j.jpba.2017.01.006.
   PubMed Web of Science ®Google Scholar
• Coelho, A.-S.; Chagas, C.-E.-P.; de Pádua, R.-M.; Pianetti, G.-A.; Fernandes, C. A Comprehensive Stability-Indicating HPLC Method for Determination of Chloroquine in Active Pharmaceutical Ingredient and Tablets: Identification of Oxidation Impurities. J. Pharm. Biomed. Anal. 2017, 145, 248–254. DOI: 10.1016/j.jpba.2017.06.023.
   PubMed Web of Science ®Google Scholar
• Aprile, S.; Canavesi, R.; Bianchi, M.; Grosa, G.; Del Grosso, E. Development and Validation of a Stability-Indicating HPLC-UV Method for the Determination of Thiocolchicoside and Its Degradation Products. J. Pharm. Biomed. Anal. 2017, 132, 66–71. DOI: 10.1016/j.jpba.2016.09.037.
   PubMed Web of Science ®Google Scholar
• Kumar, A.; Devineni, S.-R.; Dubey, S.-K.; Kumar, P.; Srivastava, V.; Ambulgekar, G.; Jain, M.; Gupta, D. K.; Singh, G.; Kumar, R.; et al. Identification Synthesis and Structural Characterization of Process Related and Degradation Impurities of Acrivastine and Validation of HPLC Method. J. Pharm. Biomed. Anal. 2017, 133, 15–26. DOI: 10.1016/j.jpba.2016.10.015.
   PubMed Web of Science ®Google Scholar
• Luo, Z.; Liu, A.; Liu, Y.; Wang, G.; Chen, X.; Wang, H.; Li, M.; Zhang, H.; Qiu, Y.; Zhai, H. Development of a Stability– Indicating HPLC Method for Simultaneous Determination of Ten Related Substances in Vonoprazan Fumarate Drug Substance. J. Pharm. Biomed. Anal. 2018, 149, 133–142. DOI: 10.1016/j.jpba.2017.11.011.
   PubMed Web of Science ®Google Scholar
• Dispas, A.; Desfontaine, V.; Andri, B.; Lebrun, P.; Kotoni, D.; Clarke, A.; Guillarme, D.; Hubert, P. Quantitative Determination of Salbutamol Sulfate Impurities Using Achiral Supercritical Fluid Chromatography. J. Pharm. Biomed. Anal. 2017, 134, 170–180. DOI: 10.1016/j.jpba.2016.11.039.
   PubMed Web of Science ®Google Scholar
• Mansour, M.-F.; Zhu, P.; Van Schepdael, A.; Adams, E. Development and Validation of a Liquid Chromatographic Method for the Analysis of Squaric Acid Dibutyl Ester and Its Impurities. J. Pharm. Biomed. Anal. 2017, 141, 165–172. DOI: 10.1016/j.jpba.2017.04.022.
   PubMed Web of Science ®Google Scholar
• Niedermeier, E.; Scriba, G.-K.-E. A Quality by Design-Based Approach to a Capillary Electrokinetic Assay for the Determination of Dextromepromazine and Levomepromazine Sulfoxide as Impurities of Levomepromazine. J. Pharm. Biomed. Anal. 2017, 146, 402–409. DOI: 10.1016/j.jpba.2017.09.003.
   PubMed Web of Science ®Google Scholar
• Devrukhakar, P.-S; Shiva Shankar, M.; Shankar, G.; Srinivas, R. A Stability Indicating HPLC Method of Zidovudine: validation, Characterization and Toxicity Prediction of Two Major Acid Degradation Products. J. Pharm. Anal., 2017, 7, 1–7. DOI: 10.1016/j.jpha.2017.01.006.
   PubMed Web of Science ®Google Scholar
• Kurmi, M.; Sahu, A.; Tiwari, S.-K.; Singh, S. Stability Behaviour of Antiretroviral Drugs and Their Combinations. 6: Evidence of Formation of Potentially Toxic Degradation Products of Zidovudine under Hydrolytic and Photolytic Conditions. RSC Adv. 2017, 7, 18803–18814. DOI: 10.1039/C7RA00678K.
   Web of Science ®Google Scholar
• Johnsirani, P.; Ch, V.; Lingesh, A.; Naidu, V.-G.-M.; Ch, N.; Satheeshkumar, N. Isolation, Characterization Using LC-ESI-QTOF, NMR and in Vitro Cytotoxicity Assay of Niclosamide Forced Degradation Products. J. Pharm. Biomed. Anal. 2017, 136, 148–155. DOI: 10.1016/j.jpba.2017.01.001.
   PubMed Web of Science ®Google Scholar
• Pinheiro, M.-S.; Viana, G.-M.; B. de, A.-A.; Vieira, A.-M.-T.; de Souza, C.-R.; Rodrigues, R.; Marins de, C.-E.-E.; Cabral, L.-M.; de Sousa, V.-P. Identification, Characterization and in Silico ADMET Prediction of Roflumilast Degradation Products. J. Pharm. Biomed. Anal. 2017, 138, 126–133. DOI: 10.1016/j.jpba.2017.02.012.
   PubMed Web of Science ®Google Scholar
• Lei, Y.; Jin, B.; Ma, C.; Zhang, T.; Li, T. Identification of Forced Degradation Products of Tedizolid Phosphate by Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry. J. Pharm. Biomed. Anal. 2017, 139, 221–231. DOI: 10.1016/j.jpba.2017.03.006.
   PubMed Web of Science ®Google Scholar
• Kryczyk, A.; Żmudzki, P.; Koczurkiewicz, P.; Piotrowska, J.; Pękala, E.; Hubicka, U. The Impact of ZnO and TiO2on the Stability of Clotrimazole under UVA Irradiation: Identification of Photocatalytic Degradation Products and in Vitro Cytotoxicity Assessment. J. Pharm. Biomed. Anal. 2017, 145, 283–292. DOI: 10.1016/j.jpba.2017.06.043.
   PubMed Web of Science ®Google Scholar
• Kurmi, M.; Sahu, A.; Singh, D.-K.; Singh, I.-P.; Singh, S. Stability Behaviour of Antiretroviral Drugs and Their Combinations. 8: Characterization and in-Silico Toxicity Prediction of Degradation Products of Efavirenz. J. Pharm. Biomed. Anal. 2018, 148, 170–181. DOI: 10.1016/j.jpba.2017.09.029.
   PubMed Web of Science ®Google Scholar
• Bhavani, G.; Krishna, B.-M.; Srinivasu, N.; Ramachandran, D.; Raman, V.-V.-S.-S.; Babu, H. Determination of Genotoxic Impurity in Atazanavir Sulphate Drug Substance by LC–MS. J. Pharm. Biomed. Anal. 2017, 132, 156–158. DOI: 10.1016/j.jpba.2016.09.025.
   PubMed Web of Science ®Google Scholar
• Jain, M.; Srivastava, V.; Kumar, R.; Dangi, V.; Hiriyanna, S.-G.; Kumar, A.; Kumar, P. Determination of Five Potential Genotoxic Impurities in Dalfampridine Using Liquid Chromatography. J. Pharm. Biomed. Anal. 2017, 133, 27–31. DOI: 10.1016/j.jpba.2016.10.013.
   PubMed Web of Science ®Google Scholar
• Grigori, K.; Loukas, Y.-L.; Malenović, A.; Samara, V.; Kalaskani, A.; Dimovasili, E.; Kalovidouri, M.; Dotsikas, Y. Chemometrically Assisted Development and Validation of LC–MS/MS Method for the Analysis of Potential Genotoxic Impurities in Meropenem Active Pharmaceutical Ingredient. J. Pharm. Biomed. Anal. 2017, 145, 307–314. DOI: 10.1016/j.jpba.2017.06.061.
   PubMed Web of Science ®Google Scholar
• Zacharis, C.-K.; Vastardi, E. Application of Analytical Quality by Design Principles for the Determination of Alkyl p-Toluenesulfonates Impurities in Aprepitant by HPLC. Validation Using Total-Error Concept. J. Pharm. Biomed. Anal. 2018, 150, 152–161. DOI: 10.1016/j.jpba.2017.12.009.
   PubMed Web of Science ®Google Scholar
• Iliou, K.; Malenović, A.; Loukas, Y.-L.; Dotsikas, Y. Analysis of Potential Genotoxic Impurities in Rabeprazole Active Pharmaceutical Ingredient via Liquid Chromatography-Tandem Mass Spectrometry, following Quality-by-Design Principles for Method Development. J. Pharm. Biomed. Anal. 2018, 149, 410–418. DOI: 10.1016/j.jpba.2017.11.037.
   PubMed Web of Science ®Google Scholar
• Kaushik, K.; Kaur, J.; Paul Kaur, V.; Saini, B.; Bansal, Y.; Bansal, G. Forced Degradation, LC-UV, MSnand LC-MS-TOF Studies on Azilsartan: Identification of a Known and Three New Degradation Impurities. J. Pharm. Biomed. Anal. 2016, 120, 202–211. DOI: 10.1016/j.jpba.2015.12.027.
   PubMed Web of Science ®Google Scholar
• Kumar, N.; Devineni, S.-R.; Gajjala, P.-R.; Gupta, D.-K.; Bhat, S.; Kumar, R.; Dubey, S.-K.; Kumar, P. Four Process-Related Potential New Impurities in Ticagrelor: Identification, Isolation, Characterization Using HPLC, LC/ESI-MS(n), NMR and Their Synthesis. J. Pharm. Biomed. Anal. 2016, 120, 248–260. DOI: 10.1016/j.jpba.2015.12.037.
   PubMed Web of Science ®Google Scholar
• Kumar, N.; Devineni, S.-R.; Singh, G.; Kadirappa, A.; Dubey, S.-K.; Kumar, P. Identification, Isolation and Characterization of Potential Process-Related Impurity and Its Degradation Product in Vildagliptin. J. Pharm. Biomed. Anal. 2016, 119, 114–121. DOI: 10.1016/j.jpba.2015.11.044.
   PubMed Web of Science ®Google Scholar
• Sastry, R.-V.-R.-P.; Venkatesan, C.-S.; Sastry, B.-S.; Mahesh, K. Identification and Characterization of Forced Degradation Products of Pralatrexate Injection by LC-PDA and LC–MS. J. Pharm. Biomed. Anal. 2016, 131, 400–409. DOI: 10.1016/j.jpba.2016.08.023.
   PubMed Web of Science ®Google Scholar
• Ye, Q.; Ding, W.; Rinaldi, F.; Huang, Y.; Miller, S.-A.; Bolgar, M. Structural Characterization of Low Level Degradants in Aztreonam Injection and an Innovative Approach to Aid HPLC Method Validation. J. Pharm. Biomed. Anal. 2016, 124, 358–364. DOI: 10.1016/j.jpba.2016.03.017.
   PubMed Web of Science ®Google Scholar
• Chadha, R.; Bali, A.; Bansal, G. Characterization of Stress Degradation Products of Duloxetine Hydrochloride Employing LC-UV/PDA and LC-MS/TOF Studies. J. Pharm. Biomed. Anal. 2016, 121, 39–55. DOI: 10.1016/j.jpba.2016.01.002.
   PubMed Web of Science ®Google Scholar
• Ragham, P.-K.; Chandrasekhar, K.-B. Development and Validation of a Stability-Indicating RP-HPL C-CAD Method for Gabapentin and Its Related Impurities in Presence of Degradation Products. J. Pharm. Biomed. Anal. 2016, 125, 122–129. DOI: 10.1016/j.jpba.2016.03.035.
   PubMed Web of Science ®Google Scholar
• Reddy, R.-B.; More, K.-R.; Jha, M.-S.; Sharma, B.; Magar, L. Identification, Synthesis, Isolation and Characterization of Formulation Related Impurity of Gabapentin. J. Pharm. Biomed. Anal. 2016, 129, 509–513. DOI: 10.1016/j.jpba.2016.07.035.
   PubMed Web of Science ®Google Scholar
• Kurmi, M.; Singh, D.-K.; Tiwari, S.; Sharma, P.; Singh, S. Stability Behaviour of Antiretroviral Drugs and Their Combinations. 3: Characterization of Interaction Products of Emtricitabine and Tenofovir Disoproxil Fumarate by Mass Spectrometry. J. Pharm. Biomed. Anal. 2016, 128, 438–446. DOI: 10.1016/j.jpba.2016.06.021.
   PubMed Web of Science ®Google Scholar
• Zhang, F.; Zhou, J.; Shi, Y.; Tavlarakis, P.; Karaisz, K. Mechanism Driven Structural Elucidation of Forced Degradation Products from Hydrocortisone in Solution. J. Pharm. Biomed. Anal. 2016, 128, 333–341. DOI: 10.1016/j.jpba.2016.06.004.
   PubMed Web of Science ®Google Scholar
• Chiguru, V.; Lingesh, A.; Srinivas, R.; Satheeshkumar, N. Forced Degradation Study of Racecadotril: Effect of Co-Solvent, Characterization of Degradation Products by UHPLC-Q-TOF-MS/MS, NMR and Cytotoxicity Assay. J. Pharm. Biomed. Anal. 2016, 128, 9–17. DOI: 10.1016/j.jpba.2016.05.008.
   PubMed Web of Science ®Google Scholar
• Liu, M.; Wang, J.; Liu, P. HPLC Method Development, Validation, and Impurity Characterization of a Potent Antitumor Nucleoside. T-dCyd (NSC 764276). J. Pharm. Biomed. Anal. 2016, 131, 429–435. DOI: 10.1016/j.jpba.2016.08.034.
   PubMed Web of Science ®Google Scholar
• Wingert, N.-R.; dos Santos, N.-O.; Nunes, M.-A.-G.; Gomes, P.; Müller, E.-I.; Flores, E.-M.-M.; Steppe, M. Characterization of Three Main Degradation Products from Novel Oral Anticoagulant Rivaroxaban under Stress Conditions by UPLC-Q-TOF-MS/MS. J. Pharm. Biomed. Anal. 2016, 123, 10–15. DOI: 10.1016/j.jpba.2016.01.053.
   PubMed Web of Science ®Google Scholar
• Ludvigsson, J-w.; Andersson, T.; Kjellberg, V. A New Method to Identify Hydrolytic Degradants in Drug Substances with UPLC-MS Using 18O-Labelled Water. J. Pharm. Biomed. Anal. 2016, 122, 9–15. DOI: 10.1016/j.jpba.2016.01.041.
   PubMed Web of Science ®Google Scholar
• Bērziņš, K.; Kons, A.; Grante, I.; Dzabijeva, D.; Nakurte, I.; Actiņš, A. Multi-Technique Approach for Qualitative and Quantitative Characterization of Furazidin Degradation Kinetics under Alkaline Conditions. J. Pharm. Biomed. Anal. 2016, 129, 433–440. DOI: 10.1016/j.jpba.2016.07.039.
   PubMed Web of Science ®Google Scholar
• Tian, J.; Rustum, A. Development and Validation of a Fast Static Headspace GC Method for Determination of Residual Solvents in Permethrin. J. Pharm. Biomed. Anal. 2016, 128, 408–415. DOI: 10.1016/j.jpba.2016.06.020.
   PubMed Web of Science ®Google Scholar
• Stepanovs, D.; Tetere, Z.; Rāviņa, I.; Kumpiņš, V.; Zicāne, D.; Bizdēna, Ē.; Bogans, J.; Novosjolova, I.; Grigaloviča, A.; Meri, R. M.; et al. Structural Characterization of Cevimeline and Its Trans-Impurity by Single Crystal XRD. J. Pharm. Biomed. Anal. 2016, 118, 404–409. DOI: 10.1016/j.jpba.2015.11.006.
   PubMed Web of Science ®Google Scholar
• Plachká, K.; Chrenková, L.; Douša, M.; Nováko, L. Development, Validation and Comparison of UHPSFC and UHPLC Methods for the Determination of Agomelatine and Its Impurities. J. Pharm. Biomed. Anal. 2016, 125, 376–384. DOI: 10.1016/j.jpba.2016.04.020.
   PubMed Web of Science ®Google Scholar
• Kurmi, M.; Kushwah, B.-S.; Sahu, A.; Narayanam, M.; Singh, S. Stability Behaviour of Antiretroviral Drugs and Their Combinations. 2: Characterization of Interaction Products of Lamivudine and Tenofovir Disoproxil Fumarate by Mass and NMR Spectrometry. J. Pharm. Biomed. Anal. 2016, 125, 245–259. DOI: 10.1016/j.jpba.2016.03.039.
   PubMed Web of Science ®Google Scholar
• Kühnreich, R.; Holzgrabe, U. Impurity Profiling of l-Methionine by HPLC on a Mixed Mode Column. J. Pharm. Biomed. Anal. 2016, 122, 118–125. DOI:10.1016/j.jpba.2016.01.057.
   PubMed Web of Science ®Google Scholar
• Omotani, H.; Yasuda, M.; Ishii, R.; Ikarashi, T.; Fukuuchi, T.; Yamaoka, N.; Mawatari, K.-I.; Kaneko, K.; Nakagomi, K. Analysis of l-DOPA-Derived Melanin and a Novel Degradation Product Formed under Alkaline Conditions. J. Pharm. Biomed. Anal. 2016, 125, 22–26. DOI: 10.1016/j.jpba.2016.03.019.
   PubMed Web of Science ®Google Scholar
• Reddy, R.-B.; More, K.-R.; Gupta, L.; Jha, M.-S.; Magar, L. Identification, Synthesis, Isolation and Characterization of New Impurity in Metoprolol Tartrate Tablets. J. Pharm. Biomed. Anal. 2016, 117, 104–108. DOI: 10.1016/j.jpba.2015.08.039.
   PubMed Web of Science ®Google Scholar
• Ma, X.; Zhou, W.; Zou, Q.; Ouyang, P. Structural Elucidation of the Impurities in Enzalutamide Bulk Drug and the Development, Validation of Corresponding HPLC Method. J. Pharm. Biomed. Anal. 2016, 131, 436–443. DOI: 10.1016/j.jpba.2016.08.036.
   PubMed Web of Science ®Google Scholar
• Xu, Q.; Tan, S.; Petrova, K. Development and Validation of a Hydrophilic Interaction Chromatography Method Coupled with a Charged Aerosol Detector for Quantitative Analysis of Nonchromophoric α-Hydroxyamines, Organic Impurities of Metoprolol. J. Pharm. Biomed. Anal. 2016, 118, 242–250. DOI: 10.1016/j.jpba.2015.11.002.
   PubMed Web of Science ®Google Scholar
• Zhang, H.; Sun, L.; Zou, L.; Hui, W.; Liu, L.; Zou, Q.; Ouyang, P. Identification, Characterization and HPLC Quantification of Process-Related Impurities in Trelagliptin Succinate Bulk Drug: Six Identified as New Compounds. J. Pharm. Biomed. Anal. 2016, 128, 18–27. DOI: 10.1016/j.jpba.2016.04.041.
   PubMed Web of Science ®Google Scholar
• Yang, Y.; Zhu, X.; Zhang, F.; Li, W.; Wu, Y.; Ding, L. Stability-Indicating HPLC Method Development and Structural Elucidation of Novel Degradation Products in Posaconazole Injection by LC-TOF/MS, LC-MS/MS and NMR. J. Pharm. Biomed. Anal. 2016, 125, 165–177. DOI: 10.1016/j.jpba.2016.03.034.
   PubMed Web of Science ®Google Scholar
• Reis, N.-F.-A.; de Assis, J.-C.; Fialho, S.-L.; Pianetti, G.-A.; Fernandes, C. Stability-Indicating UHPLC Method for Determination of Nevirapine in Its Bulk Form and Tablets: Identification of Impurities and Degradation Kinetic Study. J. Pharm. Biomed. Anal. 2016, 126, 103–108. DOI: 10.1016/j.jpba.2016.05.005.
   PubMed Web of Science ®Google Scholar
• Reddy, V.-B.; Yusop, Z.; Jaafar, J.; Aris, A.-B.; Majid, Z.-A.; Umar, K.; Talib, J. Development and Validation of a Selective, Sensitive and Stability Indicating UPLC-MS/MS Method for Rapid, Simultaneous Determination of Six Process Related Impurities in Darunavir Drug Substance. J. Pharm. Biomed. Anal. 2016, 128, 141–148. DOI: 10.1016/j.jpba.2016.05.026.
   PubMed Web of Science ®Google Scholar
• Runje, M.; Babić, S.; Meštrović, E.; Nekola, I.; Dujmić-Vučinić, Z.; Vojčić, N. Forced Degradation of Nepafenac: Development and Validation of Stability Indicating UHPLC Method. J. Pharm. Biomed. Anal. 2016, 123, 42–52. DOI: 10.1016/j.jpba.2016.02.003.
   PubMed Web of Science ®Google Scholar
• Jadhav, S.-B.; Kumar, C.-K.; Bandichhor, R.; Bhosale, P.-N. Development of RP UPLC-TOF/MS, Stability Indicating Method for Omeprazole and Its Related Substances by Applying Two Level Factorial Design; and Identification and Synthesis of Non-Pharmacopoeial Impurities. J. Pharm. Biomed. Anal. 2016, 118, 370–379. DOI: 10.1016/j.jpba.2015.10.005.
   PubMed Web of Science ®Google Scholar
• Terzić, J.; Popović, I.; Stajić, A.; Tumpa, A.; Jančić-Stojanovic, B. Application of Analytical Quality by Design Concept for Bilastine and Its Degradation Impurities Determination by Hydrophilic Interaction Liquid Chromatographic Method. J. Pharm. Biomed. Anal. 2016, 125, 385–393. DOI: 10.1016/j.jpba.2016.04.022.
   PubMed Web of Science ®Google Scholar
• Maksić, J.; Tumpa, A.; Stajić, A.; Jovanović, M.; Rakić, T.; Jancic-Stojanovic, B. Hydrophilic Interaction Liquid Chromatography in Analysis of Granisetron HCl and Its Related Substances. Retention Mechanisms and Method Development. J. Pharm. Biomed. Anal. 2016, 123, 93–103. DOI: 10.1016/j.jpba.2016.02.010.
   PubMed Web of Science ®Google Scholar
• Swain, D.; Samanthula, G.; Bhagat, S.; Bharatam, P.-V.; Akula, P.-V.; Sinha, B.-N. Characterization of Forced Degradation Products and in Silico Toxicity Prediction of Sofosbuvir: A Novel HCV NS5B Polymerase Inhibitor. J. Pharm. Biomed. Anal. 2016, 116, 352–363. DOI: 10.1016/j.jpba.2015.12.045.
   Google Scholar
• Gričar, M.; Andrenšek, S. Determination of Azide Impurity in Sartans Using Reversed-Phase HPLC with UV Detection. J. Pharm. Biomed. Anal. 2016, 125, 27–32. DOI: 10.1016/j.jpba.2016.03.020.
   PubMed Web of Science ®Google Scholar
• Wang, J.; Yang, S.; Zhang, K. A Simple and Sensitive Method to Analyze Genotoxic Impurity Hydrazine in Pharmaceutical Materials. J. Pharm. Biomed. Anal. 2016, 126, 141–147. DOI: 10.1016/j.jpba.2016.04.038.
   PubMed Web of Science ®Google Scholar
• Kumar Pandey, A.; Rapolu, R.; Raju, C.-K.; Sasalamari, G.; Kumar, G.-S.; Awasthi, A.; Navalgund, S.-G.; Surendranath, K.-V. The Novel Acid Degradation Products of Losartan: Isolation and Characterization Using Q-TOF, 2D-NMR and FTIR. J. Pharm. Biomed. Anal. 2016, 120, 65–71. DOI: 10.1016/j.jpba.2015.11.037.
   PubMed Web of Science ®Google Scholar
• Santos, M.; García, L.-C.; Checura, C.; Donadío, L.-G.; Fernandez, C.; Orgueira, H.; Comin, M.-J. Synthesis and Characterization of New Related Substances of the Antiarrhythmic Drug Dronedarone Hydrochloride. J. Pharm. Biomed. Anal. 2015, 114, 441–446. DOI: 10.1016/j.jpba.2015.06.026.
   PubMed Web of Science ®Google Scholar
• Oh, H.-A.; Kim, D.; Lee, S.-H.; Jung, B.-H. Simultaneous Quantitative Determination of Celecoxib and Its Two Metabolites Using Liquid Chromatography-Tandem Mass Spectrometry in Alternating Polarity Switching Mod. J. Pharm. Biomed. Anal. 2015, 107, 32–39. DOI: 10.1016/j.jpba.2014.12.004.
   PubMed Web of Science ®Google Scholar
• Wahl, O.; Holzgrabe, U. Impurity Profiling of Ibandronate Sodium by HPLC-CAD. J. Pharm. Biomed. Anal. 2015, 144, 254–264. DOI: 10.1016/j.jpba.2015.06.002.
   Google Scholar
• Pantović, J.; Malenović, A.; Vemić, A.; Kostić, N.; Medenica, M. Development of Liquid Chromatographic Method for the Analysis of Dabigatran Etexilate Mesilate and Its Ten Impurities Supported by Quality-by-Design Methodology. J. Pharm. Biomed. Anal. 2015, 111, 7–13. DOI: 10.1016/j.jpba.2015.03.009.
   PubMed Web of Science ®Google Scholar
• Zhu, P.; Yang, W.; Hong, L.; Cheng, Q.; Luo, L.; He, J.; Chen, J. Characterization of a Novel Process-Related Impurity in Commercial Bendazac Lysine Eye Drops by LC–ESI-QTOF/MS/MS and NMR. J. Pharm. Biomed. Anal. 2015, 107, 437–443. DOI: 10.1016/j.jpba.2015.01.002.
   PubMed Web of Science ®Google Scholar
• Narayanam, M.; Sahu, A.; Singh, S. Use of LC-MS/TOF, LC-MSn, NMR and LC-NMR in Characterization of Stress Degradation Products: Application to Cilazapril. J. Pharm. Biomed. Anal. 2015, 111, 190–203. DOI: 10.1016/j.jpba.2015.03.038.
   PubMed Web of Science ®Google Scholar
• Chadha, R.; Bali, A.; Bansal, G. Identification and Characterization of Stress Degradation Products of Dronedarone Hydrochloride Employing LC-UV/PDA, LC–MS/TOF and MSn Studies. J. Pharm. Biomed. Anal. 2016, 110, 139–148. DOI: 10.1016/j.jpba.2015.10.028.
   Google Scholar
• Stypulkowska, K.; Blazewicz, A.; Brudzikowska, A.; Warowna-Grzeskiewicz, M.; Sarna, K.; Fijalek, Z. Development of High Performance Liquid Chromatography Methods with Charged Aerosol Detection for the Determination of Lincomycin, Spectinomycin and Its Impurities in Pharmaceutical Products. J. Pharm. Biomed. Anal. 2015, 112, 8–14. DOI: 10.1016/j.jpba.2015.03.030.
   PubMed Web of Science ®Google Scholar
• Wang, D.; Wang, F.; Wang, J. Characterization of the Impurities and Isomers in Cefetamet Pivoxil Hydrochloride by Liquid Chromatography/Time-of-Flight Mass Spectrometry and Ion Trap Mass Spectrometry. J. Pharm. Biomed. Anal. 2015, 113, 71–77. DOI: 10.1016/j.jpba.2015.03.013.
   Google Scholar
• Li, P.; Wang, L.; Song, M.; Hang, T. Identification and Characterization of Related Substances in Pomalidomide by Hyphenated LC-MS Techniques. J. Pharm. Biomed. Anal. 2015, 114, 159–167. DOI: 10.1016/j.jpba.2015.05.018.
   PubMed Web of Science ®Google Scholar
• Patel, P.-N.; Kalariya, P.-D.; Gananadhamu, S.; Srinivas, R. Forced Degradation of Fingolimod: Effect of co-Solvent and Characterization of Degradation Products by UHPLC-Q-TOF-MS/MS and 1H NMR. J. Pharm. Biomed. Anal. 2015, 115, 388–394. DOI: 10.1016/j.jpba.2015.07.028.
   PubMed Web of Science ®Google Scholar
• Zalewski, P.; Skibiński, R.; Talaczyńska, A.; Paczkowska, M.; Garbacki, P.; Cielecka-Piontek, J. Stability Studies of Cefoselis Sulfate in the Solid State. J. Pharm. Biomed. Anal. 2015, 115, 222–226. DOI: 10.1016/j.jpba.2015.05.031.
   Google Scholar
• Abdelaleem, E.-A.; Naguib, I.-A.; Hassan, E.-S.; Ali, N.-W. HPTLC and RP-HPLC Methods for Simultaneous Determination of Paracetamol and Pamabrom in Presence of Their Potential Impurities. J. Pharm. Biomed. Anal. 2015, 116, 22–27. DOI: 10.1016/j.jpba.2015.04.030.
   Google Scholar
• Li, W.; Wang, J.; Yan, Z.-Y. Development of a Sensitive and Rapid Method for Rifampicin Impurity Analysis Using Supercritical Fluid Chromatography. J. Pharm. Biomed. Anal. 2015, 114, 341–347. DOI: 10.1016/j.jpba.2015.06.012.
   PubMed Web of Science ®Google Scholar
• Galea, C.; Mangelings, D.; Vander, H.-Y. Method Development for Impurity Profiling in SFC: The Selection of a Dissimilar Set of Stationary Phases. J. Pharm. Biomed. Anal. 2015, 111, 333–343. DOI: 10.1016/j.jpba.2014.12.043.
   PubMed Web of Science ®Google Scholar
• Liu, L.; Cao, N.; Ma, X.; Xiong, K.; Sun, L.; Zou, Q.; Yao, L. Stability-Indicating Reversed-Phase HPLC Method Development and Characterization of Impurities in Vortioxetine Utilizing LC-MS, IR and NMR. J. Pharm. Biomed. Anal. 2016, 116, 325–332. DOI: 10.1016/j.jpba.2015.08.028.
   Google Scholar
• Vojta, J.; Jedlička, A.; Coufal, P.; Janečková, L. A New, Rapid, Stability-Indicating UPLC Method for Separation and Determination of Impurities in Amlodipine Besylate, Valsartan and Hydrochlorothiazide in Their Combined Tablet Dosage Form. J. Pharm. Biomed. Anal. 2015, 116, 36–44. DOI: 10.1016/j.jpba.2015.01.059.
   Google Scholar
• Peterka, T.-R.; Grahek, R.; Hren, J.; Bastarda, A.; Bergles, J.; Urleb, U. Solid State Compatibility Study and Characterization of a Novel Degradation Product of Tacrolimus in Formulation. J. Pharm. Biomed. Anal. 2015, 110, 67–75. DOI: 10.1016/j.jpba.2015.02.28.
   PubMed Web of Science ®Google Scholar
• Fanigliulo, A.; De Filippis, P.; Curcuruto, O.; Repeto, P.; Roveda, D.; Hartenstein, M.; Adams, E.; Cabooter, D. Development and Validation of a Stability Indicating Method for S-Carboxymethyl-l-Cysteine and Related Degradation Products in Oral Syrup Formulation. J. Pharm. Biomed. Anal. 2015, 115, 39–47. DOI: 10.1016/j.jpba.2015.06.031.
   PubMed Web of Science ®Google Scholar
• Zhang, D.; Su, J. Investigation of Reduction Process and Related Impurities in Ezetimibe. J. Pharm. Biomed. Anal. 2015, 107, 355–363. DOI: 10.1016/j.jpba.2015.01.008.
   PubMed Web of Science ®Google Scholar
• Jovanović, M.; Rakić, T.; Tumpa, A.; Jančić Stojanović, B. Quality by Design Approach in the Development of Hydrophilic Interaction Liquid Chromatographic Method for the Analysis of Iohexol and Its Impurities. J. Pharm. Biomed. Anal. 2015, 111, 42–48. DOI: 10.1016/j.jpba.2015.02.28.
   Web of Science ®Google Scholar
• Boussès, C.; Ferey, L.; Vedrines, E.; Gaudin, K. Using an Innovative Combination of Quality-by-Design and Green Analytical Chemistry Approaches for the Development of a Stability Indicating UHPLC Method in Pharmaceutical Products. J. Pharm. Biomed. Anal. 2015, 115, 114–122. DOI: 10.1016/j.jpba.2015.07.003.
   PubMed Web of Science ®Google Scholar
• Rapolu, R.; Pandey, A.-K.; Raju, C.-K.; Ghosh, K.; Srinivas, K.; Awasthi, A.; Navalgund, S.-G.; Surendranath, K.-V. A Novel UV Degradation Product of Ebastine: Isolation and Characterization Using Q-TOF, NMR, IR and Computational Chemistry. J. Pharm. Biomed. Anal. 2015, 107, 488–494. DOI: 10.1016/j.jpba.2015.01.039.
   PubMed Web of Science ®Google Scholar
• Ramesh, T.; Nageswara Rao, P.; Nageswara Rao, R. LC-MS/MS Characterization of Forced Degradation Products of Zofenopril. J. Pharm. Biomed. Anal. 2014, 88, 609–616. DOI: 10.1016/j.jpba.2013.10.018.
   PubMed Web of Science ®Google Scholar
• Rao, R.-N.; Ramachandra, B.; Sravan, B.; Khalid, S. LC-MS/MS Structural Characterization of Stress Degradation Products Including the Development of a Stability Indicating Assay of Darunavir: An anti-HIV Drug. J. Pharm. Biomed. Anal. 2014, 89, 28–33. DOI: 10.1016/j.jpba.2013.10.007.
   PubMed Web of Science ®Google Scholar
• Zhang, D.; Song, X.; Su, J. Isolation, Identification and Characterization of Novel Process-Related Impurities in Flupirtine Maleate. J. Pharm. Biomed. Anal. 2014, 90, 27–34. DOI: 10.1016/j.jpba.2013.11.015.
   PubMed Web of Science ®Google Scholar
• Regalado, E.-L.; Dermenjian, R.-K.; Joyce, L.-A.; Welch, C.-J. Detection of Dehalogenation Impurities in Organohalogenated Pharmaceuticals by UHPLC-DAD-HRESIMS. J. Pharm. Biomed. Anal. 2014, 90, 1–5. DOI: 10.1016/j.jpba.2013.12.043.
   PubMedGoogle Scholar
• Gana, I.; Dugay, A.; Henriet, T.; Rietveld, I.-B.; Bernard, M.; Guechot, C.; Teulon, J.-M.; Safta, F.; Yagoubi, N.; Céolin, R.; Do, B. Degradation Pathways Study of the Natriuretic and β-Adrenoceptor Antagonist Tienoxolol Using Liquid Chromatography-Electrospray Ionization Multistage Mass Spectrometry. J. Pharm. Biomed. Anal. 2014, 89, 58–67. DOI: 10.1016/j.jpba.2014.03.016.
   Google Scholar
• Handa, T.; Singh, S.; Singh, I.-P. Characterization of a New Degradation Product of Nifedipine Formed on Catalysis by Atenolol: A Typical Case of Alteration of Degradation Pathway of One Drug by Another. J. Pharm. Biomed. Anal. 2014, 89, 6–17. DOI: 10.1016/j.jpba.2013.10.024.
   PubMed Web of Science ®Google Scholar
• Prakash, L.; Himaja, M.; Subbaiah, B.-V.; Vasudev, R.; Srinivasulu, C.; Haribabu, R. Isolation, Identification and Characterization of Degradant Impurities in Tolterodine Tartrate Formulation. J. Pharm. Biomed. Anal. 2014, 90, 215–221. DOI: 10.1016/j.jpba.2013.12.007.
   PubMed Web of Science ®Google Scholar
• Bourezg, Z.; Cartiser, N.; Ettouati, L.; Guillon, J.; Lacoudre, A.; Pinaud, N.; Le Borgne, M.; Fessi, H. Structural Elucidation of Two Photolytic Degradation Products of Tetrabenazine. J. Pharm. Biomed. Anal. 2014, 89, 138–143. DOI: 10.1016/j.jpba.2013.12.032.
   Google Scholar
• Douša, M.; Srbek, J.; Rádl, S.; Černý, J.; Klecán, O.; Havlíček, J.; Tkadlecová, M.; Pekárek, T.; Gibala, P.; Nováková, L. Identification, Characterization, Synthesis and HPLC Quantification of New Process-Related Impurities and Degradation Products in Retigabine. J. Pharm. Biomed. Anal. 2014, 94, 71–76. DOI: 10.1016/j.jpba.2014.01.042.
   PubMed Web of Science ®Google Scholar
• Vojta, J.; Hanzlík, P.; Jedlička, A.; Coufal, P. Separation and Determination of Impurities in Paracetamol, Codeine and Pitophenone in the Presence of Fenpiverinium in Combined Suppository Dosage Form. J. Pharm. Biomed. Anal. 2015, 102, 85–92. DOI: 10.1016/j.jpba.2014.09.002.
   PubMed Web of Science ®Google Scholar
• Wahl, O.; Holzgrabe, U. Impurity Profiling of Carbocisteine by HPLC-CAD, qNMR and UV/Vis Spectroscopy. J. Pharm. Biomed. Anal. 2014, 90, 1–10. DOI: 10.1016/j.jpba.2014.02.012.
   PubMedGoogle Scholar
• Anandgaonkar, V.; Gupta, A.; Kona, S.; Talluri, M.-V.-N.-K. Isolation, LC-MS/MS and 2D-NMR Characterization of Alkaline Degradants of Tenofovir Disoproxil Fumarate. J. Pharm. Biomed. Anal. 2015, 107, 175–185. DOI: 10.1016/j.jpba.2014.12.034.
   PubMed Web of Science ®Google Scholar
• Kumar Talluri, M.-V.-N.; Dharavath, S.; Kalariya, P.-D.; Prasanth, B.; Srinivas, R. Structural Characterization of Alkaline and Oxidative Stressed Degradation Products of Lurasidone Using LC/ESI/QTOF/MS/MS. J. Pharm. Biomed. Anal. 2015, 105, 1–9. DOI: 10.1016/j.jpba.2014.11.035.
   PubMed Web of Science ®Google Scholar
• Panyala, N.-R.; Sturzbecher-Hoehne, M.; Abergel, R.-J. Identification of Process Related Trace Level Impurities in the Actinide Decorporation Agent 3,4,3-LI(1,2-HOPO): Nozzle-Skimmer Fragmentation via ESI LC-QTOFMS. J. Pharm. Biomed. Anal. 2014, 100, 157–166. DOI: 10.1016/j.jpba.2014.08.004.
   PubMed Web of Science ®Google Scholar
• Liu, M.; Wang, J.; Wu, X.; Wang, E.; Baptista, D.; Scott, B.; Liu, P. HPLC Method Development, Validation and Impurity Characterization for an Antitumor Hsp90 inhibitor-PU-H71 (NSC 750424). J. Pharm. Biomed. Anal. 2014, 89, 34–41. DOI: 10.1016/j.jpba.2013.10.021.
   PubMed Web of Science ®Google Scholar
• Rapolu, R.; Raju, C.-K.; Srinivas, K.; Awasthi, A.; Navalgund, S.-G.; Surendranath, K.-V. Isolation and Characterization of a Novel Acid Degradation Impurity of Amlodipine Besylate Using Q-TOF, NMR, IR and Single Crystal X-Ray. J. Pharm. Biomed. Anal. 2014, 99, 59–66. DOI: 10.1016/j.jpba.2014.07.006.
   PubMed Web of Science ®Google Scholar
• Darcsi, A.; Tóth, G.; Kökösi, J.; Béni, S. Structure Elucidation of a Process-Related Impurity of Dapoxetine. J. Pharm. Biomed. Anal. 2014, 96, 272–277. DOI: 10.1016/j.jpba.2014.04.002.
   PubMed Web of Science ®Google Scholar
• Wang, Y.; Zhang, Z.; Wu, L.; Zhang, X.; Wang, H.; Ye, W.; Li, P. Isolation and Structure Characterization of Related Impurities in Etimicin Intermediate P1 by LC/ESI-MSnand NMR. J. Pharm. Biomed. Anal. 2014, 97, 97–102. DOI: 10.1016/j.jpba.2014.04.024.
   PubMed Web of Science ®Google Scholar
• Quirk, E.; Doggett, A.; Bretnall, A. Determination of Residual Acetone and Acetone Related Impurities in Drug Product Intermediates Prepared as Spray Dried Dispersions (SDD) Using Gas Chromatography with Headspace Autosampling (GCHS). J. Pharm. Biomed. Anal. 2014, 96, 37–44. DOI: 10.1016/j.jpba.2014.03.027.
   PubMed Web of Science ®Google Scholar
• Marley, A.; Stalcup, A. M.; Connolly, D. Development and Validation of a New Stability Indicating Reversed Phase Liquid Chromatographic Method for the Determination of Prednisolone Acetate and Impurities in an Ophthalmic Suspension. J. Pharm. Biomed. Anal. 2015, 102, 261–266. DOI: 10.1016/j.jpba.2014.09.023.
   PubMed Web of Science ®Google Scholar
• Venugopal, N.; Vijaya Bhaskar Reddy, A.; Madhavi, G. Development and Validation of a Systematic UPLC-MS/MS Method for Simultaneous Determination of Three Phenol Impurities in Ritonavir. J. Pharm. Biomed. Anal. 2014, 90, 127–133. DOI: 10.1016/j.jpba.2013.11.029.
   PubMed Web of Science ®Google Scholar
• Zalewski, P.; Skibiński, R.; Cielecka-Piontek, J. Stability Studies of Cefpirome Sulfate in the Solid State: Identification of Degradation Products. J. Pharm. Biomed. Anal. 2014, 92, 22–25. DOI: 10.1016/j.jpba.2013.12.039.
   PubMed Web of Science ®Google Scholar
• Narayanam, M.; Singh, S. Characterization of Stress Degradation Products of Fosinopril by Using LC-MS/TOF, MSnand on-Line H/D Exchange. J. Pharm. Biomed. Anal. 2014, 92, 135–143. DOI: 10.1016/j.jpba.2014.01.010.
   PubMed Web of Science ®Google Scholar
• Ramisetti, N.-R.; Kuntamukkala, R.; Lakshetti, S.; Sripadi, P. Identification and Characterization of Stress Degradants of Lacosamide by LC-MS and ESI-Q-TOF-MS/MS: Development and Validation of a Stability Indicating RP-HPLC Method. J. Pharm. Biomed. Anal. 2014, 95, 256–264. DOI: 10.1016/j.jpba.2014.03.010.
   PubMed Web of Science ®Google Scholar
• Byrne, J.; Velasco-Torrijos, T.; Reinhardt, R. Development and Validation of a Novel Stability-Indicating HPLC Method for the Simultaneous Assay of Betamethasone-17-Valerate, Fusidic Acid, Potassium Sorbate, Methylparaben and Propylparaben in a Topical Cream Preparation. J. Pharm. Biomed. Anal. 2014, 96, 111–117. DOI: 10.1016/j.jpba.2014.03.005.
   PubMed Web of Science ®Google Scholar
• Djabrouhou, N.; Guermouche, M.-H. Development of a Stability-Indicating HPLC Method of Etifoxine with Characterization of Degradation Products by LC-MS/TOF, 1H and 13C NMR. J. Pharm. Biomed. Anal. 2014, 100, 11–20. DOI: 10.1016/j.jpba.2014.07.017.
   PubMed Web of Science ®Google Scholar
• Wu, C.; Xu, X.; Feng, C.; Shi, Y.; Liu, W.; Zhu, X.; Zhang, J. Degradation Kinetics Study of Cabozantinib by a Novel Stability-Indicating LC Method and Identification of Its Major Degradation Products by LC/TOF-MS and LC-MS/MS. J. Pharm. Biomed. Anal. 2014, 98, 356–363. DOI: 10.1016/j.jpba.2014.06.008.
   PubMed Web of Science ®Google Scholar
• Canavesi, R.; Aprile, S.; Varese, E.; Grosa, G. Development and Validation of a Stability-Indicating LC-UV Method for the Determination of Pantethine and Its Degradation Product Based on a Forced Degradation Study. J. Pharm. Biomed. Anal. 2014, 97, 141–150. DOI: 10.1016/j.jpba.2014.04.025.
   PubMed Web of Science ®Google Scholar
• Hassane, S.-Y.; Secrétan, P.-H.; Henriet, T.; Bernard, M.; Amrani, F.; Akrout, W.; Tilleul, P.; Yagoubi, N.; Do, B. Identification of the Major Degradation Pathways of Ticagrelor. J. Pharm. Biomed. Anal. 2015, 105, 74–83. DOI: 10.1016/j.jpba.2014.11.046.
   PubMed Web of Science ®Google Scholar
• Kurmi, M.; Kumar, S.; Singh, B.; Singh, S. Implementation of Design of Experiments for Optimization of Forced Degradation Conditions and Development of a Stability-Indicating Method for Furosemide. J. Pharm. Biomed. Anal. 2014, 96, 135–143. DOI: 10.1016/j.jpba.2014.03.035.
   PubMed Web of Science ®Google Scholar
• Karmarkar, S.; Yang, X.; Garber, R.; Szajkovics, A.; Koberda, M. Quality by Design (QbD) Based Development and Validation of an HPLC Method for Amiodarone Hydrochloride and Its Impurities in the Drug Substance. J. Pharm. Biomed. Anal. 2014, 100, 167–174. DOI: 10.1016/j.jpba.2014.07.002.
   PubMed Web of Science ®Google Scholar
• Vemić, A.; Rakić, T.; Malenović, A.; Medenica, M. Chaotropic Salts in Liquid Chromatographic Method Development for the Determination of Pramipexole and Its Impurities following Quality-by-Design Principles. J. Pharm. Biomed. Anal. 2015, 102, 314–320. DOI: 10.1016/j.jpba.2014.09.031.
   PubMed Web of Science ®Google Scholar
• Fu, M.; Lu, Q.; Hewitt, E.; Wang, J. Ultra High Performance Liquid Chromatography Coupled with High Resolution Quantitation Mass Spectrometry Method Development and Validation for Determining Genotoxic 2,5-Dichlorobenzoyl Chloride in MLN9708 Drug Substance. J. Pharm. Biomed. Anal. 2014, 89, 233–239. DOI: 10.1016/j.jpba.2013.11.012.
   PubMed Web of Science ®Google Scholar
• Raman, N.-V.-V.-S.-S.; Prasad, A.-V.-S.-S.; Reddy, K.-R. Sensitive Derivatization Methods for the Determination of Genotoxic Impurities in Drug Substances Using Hyphenated Techniques. J. Pharm. Biomed. Anal. 2014, 89, 276–281. DOI: 10.1016/j.jpba.2013.11.013.
   PubMed Web of Science ®Google Scholar
• Zhang, H.; Wilson, J.; Zhang, J.; Luo, Y. Characterization of Potential Degradation Products in a PEGylating Reagent 20kDa Monomethoxy Polyethylene Glycol Propionaldehyde by RP-HPLC, APCI-MS and NMR. J. Pharm. Biomed. Anal. 2014, 89, 221–226. DOI: 10.1016/j.jpba.2013.10.046.
   PubMed Web of Science ®Google Scholar
• Doomkaew, A.; Prutthiwanasan, B.; Suntornsuk, L. Stability Indicating MEKC Method for the Determination of Gliclazide and Its Specified Impurities. J. Pharm. Biomed. Anal. 2015, 102, 119–128. DOI: 10.1016/j.jpba.2014.08.032.
   PubMed Web of Science ®Google Scholar
• Kahsay, G.; Shraim, F.; Villatte, P.; Rotger, J.; Cassus-Coussère, C.; Van Schepdael, A.; Hoogmartens, J.; Adams, E. Development and Validation of a Reversed Phase Liquid Chromatographic Method for Analysis of Oxytetracycline and Related Impurities. J. Pharm. Biomed. Anal. 2013, 75, 199–206. DOI: 10.1016/j.jpba.2012.11.042.
   PubMed Web of Science ®Google Scholar
• Jedynak, Ł.; Puchalska, M.; Zezula, M.; Łaszcz, M.; Łuniewski, W.; Zagrodzka, J. Stability of Sample Solution as a Crucial Point during HPLC Determination of Chemical Purity of Temozolomide Drug Substance. J. Pharm. Biomed. Anal. 2013, 83, 19–27. DOI: 10.1016/j.jpba.2013.04.032.
   PubMed Web of Science ®Google Scholar
• Doddaga, S.; Peddakonda, R. Chloroquine-N-Oxide, a Major Oxidative Degradation Product of Chloroquine: Identification, Synthesis and Characterization. J. Pharm. Biomed. Anal. 2013, 81–82, 118–125. DOI: 10.1016/j.jpba.2013.04.004.
   PubMed Web of Science ®Google Scholar
• Van den Bossche, L.; Daidone, F.; Van Schepdael, A.; Hoogmartens, J.; Adams, E. Characterization of Impurities in Josamycin Using Dual Liquid Chromatography Combined with Mass Spectrometry. J. Pharm. Biomed. Anal. 2013, 73, 66–76. DOI: 10.1016/j.jpba.2012.01.012.
   PubMed Web of Science ®Google Scholar
• Liu, Y.; Chen, L.; Ji, Y. Quantification and Structural Elucidation of Potential Impurities in Agomelatine Active Pharmaceutical Ingredient. J. Pharm. Biomed. Anal. 2013, 81–82, 193–201. DOI: 10.1016/j.jpba.2013.04.016.
   PubMed Web of Science ®Google Scholar
• Yamamoto, E.; Niijima, J.; Asakawa, N. Selective Determination of Potential Impurities in an Active Pharmaceutical Ingredient Using HPLC-SPE-HPLC. J. Pharm. Biomed. Anal. 2013, 84, 41–47. DOI: 10.1016/j.jpba.2013.05.033.
   PubMed Web of Science ®Google Scholar
• Alexander, A.-J.; Zhang, L.; Hooker, T.-F.; Tomasella, F.-P. Comparison of Supercritical Fluid Chromatography and Reverse Phase Liquid Chromatography for the Impurity Profiling of the Antiretroviral Drugs Lamivudine/BMS-986001/Efavirenz in a Combination Tablet. J. Pharm. Biomed. Anal. 2013, 78–79, 243–251. DOI: 10.1016/j.jpba.2013.02.019.
   PubMed Web of Science ®Google Scholar
• Respaud, R.; Quenum, L.; Plichon, C.; Tournamille, J.-F.; Gyan, E.; Antier, D.; Viaud-Massuard, M.-C. A Stability-Indicating, Ion-Pairing, Reversed-Phase Liquid Chromatography Method for Studies of Daunorubicin Degradation in i.v. infusion Fluids. J. Pharm. Biomed. Anal. 2013, 83, 164–170. DOI: 10.1016/j.jpba.2013.05.007.
   PubMed Web of Science ®Google Scholar
• Guntupalli, S.; Ray, U.-K.; Murali, N.; Gupta, P.-B.; Kumar, V.-J.; Satheesh, D.; Islam, A. Identification, Isolation and Characterization of Process Related Impurities in Ezetimibe. J. Pharm. Biomed. Anal. 2014, 88, 385–390. DOI: 10.1016/j.jpba.2013.09.020.
   PubMed Web of Science ®Google Scholar
• Yuan, Y.-Z.; Zhao, X.; Zhang, M.; Fan, X.-L.; Hu, C.-Q.; Jin, S.-H.; Van Schepdael, A.; Hoogmartens, J.; Adams, E. Impurity Profiling of Micronomicin Sulfate Injection by Liquid Chromatography-Ion Trap Mass Spectrometry. J. Pharm. Biomed. Anal. 2013, 75, 94–104. DOI: 10.1016/j.jpba.2012.11.029.
   PubMed Web of Science ®Google Scholar
• Nageswara Rao, R.; Ramachandra, B.; Santhakumar, K. RP-HPLC Separation and Characterization of Unknown Impurities of a Novel HIV-Protease Inhibitor Darunavir by ESI-MS and 2D NMR Spectroscopy. J. Pharm. Biomed. Anal. 2013, 75, 186–191. DOI: 10.1016/j.jpba.2012.10.022.
   PubMed Web of Science ®Google Scholar
• Jamrógiewicz, M.; Wielgomas, B. Detection of Some Volatile Degradation Products Released during Photoexposition of Ranitidine in a Solid State. J. Pharm. Biomed. Anal. 2013, 76, 177–182. DOI: 10.1016/j.jpba.2012.12.019.
   PubMed Web of Science ®Google Scholar
• Nageswara Rao, R.; Ramakrishna, K.; Sravan, B.; Santhakumar, K. RP-HPLC Separation and ESI-MS, 1H, and 13C NMR Characterization of Forced Degradants Including Process Related Impurities of Carisbamate: Method Development and Validation. J. Pharm. Biomed. Anal. 2013, 77, 49–54. DOI: 10.1016/j.jpba.2013.01.001.
   PubMed Web of Science ®Google Scholar
• Nageswara Rao, R.; Naidu, C.-G.; Prasad, K.-G.; Santhakumar, B.; Saida, S. Development and Validation of a Stability Indicating Assay of Doxofylline by RP-HPLC: ESI-MS/MS, 1H and 13C NMR Spectroscopic Characterization of Degradation Products and Process Related Impurities. J. Pharm. Biomed. Anal. 2013, 78–79, 92–99. DOI: 10.1016/j.jpba.2013.02.004.
   PubMed Web of Science ®Google Scholar
• Béni, Z.; Háda, V.; Varga, E.; Mahó, S.; Aranyi, A.; Szántay, C. New Oxidative Decomposition Mechanism of Estradiol through the Structural Characterization of a Minute Impurity and Its Degradants. J. Pharm. Biomed. Anal. 2013, 78–79, 183–189. DOI: 10.1016/j.jpba.2013.02.015.
   PubMed Web of Science ®Google Scholar
• Elkins, P.; Coleman, D.; Burgess, J.; Gardner, M.; Hines, J.; Scott, B.; Kroenke, M.; Larson, J.; Lightner, M.; Turner, G.; et al. Characterization of the Isomericconfiguration and Impurities of (Z)-Endoxifen by 2D NMR, High Resolution LC-MS, and Quantitative HPLC Analysis. J. Pharm. Biomed. Anal. 2014, 88, 174–179. DOI: 10.1016/j.jpba.2013.07.010.
   PubMed Web of Science ®Google Scholar
• Saini, B.; Bansal, G. Characterization of Four New Photodegradation Products of Hydroxychloroquine through LC-PDA, ESI-MSn and LC-MS-TOF Studies. J. Pharm. Biomed. Anal. 2013, 84, 224–231. DOI: 10.1016/j.jpba.2013.06.014.
   PubMed Web of Science ®Google Scholar
• Dall’Acqua, S.; Vedaldi, D.; Salvador, A. Isolation and Structure Elucidation of the Main UV-a Photoproducts of Vandetanib. J. Pharm. Biomed. Anal. 2013, 84, 196–200. DOI: 10.1016/j.jpba.2013.05.049.
   PubMed Web of Science ®Google Scholar
• Namdev, D.; Borkar, R.-M.; Raju, B.; Kalariya, P.-D.; Rahangdale, V.-T.; Gananadhamu, S.; Srinivas, R. Identification of Forced Degradation Products of Tamsulosin Using Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry. J. Pharm. Biomed. Anal. 2014, 88, 245–255. DOI: 10.1016/j.jpba.2013.08.052.
   PubMed Web of Science ®Google Scholar
• Jingyan, S.; Yuwen, L.; Zhiyong, W.; Cunxin, W. Investigation of Thermal Decomposition of Ascorbic Acid by TG-FTIR and Thermal Kinetics Analysis. J. Pharm. Biomed. Anal. 2013, 77, 116–119. DOI: 10.1016/j.jpba.2013.01.018.
   PubMed Web of Science ®Google Scholar
• Bansal, G.; Singh, R.; Saini, B.; Bansal, Y. ESI-MSn and LC-ESI-MS Studies to Characterize Forced Degradation Products of Bosentan and a Validated Stability-Indicating LC-UV Method. J. Pharm. Biomed. Anal. 2013, 72, 186–197. DOI: 10.1016/j.jpba.2012.08.014.
   PubMed Web of Science ®Google Scholar
• Kaushik, D.; Bansal, G. Characterization of Degradation Products of Idarubicin through LC-UV, MSn and LC-MS-TOF Studies. J. Pharm. Biomed. Anal. 2013, 85, 123–131. DOI: 10.1016/j.jpba.2013.07.002.
   PubMed Web of Science ®Google Scholar
• Rao, R.-N.; Vali, R.-M.; Raju, S.-S. Liquid Chromatography Tandem Mass Spectrometric Studies of Indinavir Sulphate and Its Forced Degradation Products. J. Pharm. Biomed. Anal. 2013, 74, 101–110. DOI: 10.1016/j.jpba.2012.10.025.
   PubMed Web of Science ®Google Scholar
• Yuan, Y.-Z.; Zhang, M.; Fan, X.-L.; Hu, C.-Q.; Jin, S.-H.; Van Schepdael, A.; Hoogmartens, J.; Adams, E. Analysis of Impurities in Vertilmicin Sulfate by Liquid Chromatography Ion-Trap Mass Spectrometry. J. Pharm. Biomed. Anal. 2013, 80, 1–8. DOI: 10.1016/j.jpba.2013.02.026.
   PubMed Web of Science ®Google Scholar
• Kahsay, G.; Adegoke, A.-O.; Van Schepdael, A.; Adams, E. Development and Validation of a Reversed Phase Liquid Chromatographic Method for Analysis of Griseofulvin and Impurities. J. Pharm. Biomed. Anal. 2013, 80, 9–17. DOI: 10.1016/j.jpba.2013.02.035.
   PubMed Web of Science ®Google Scholar
• Mabrouk, M.; El-Fatatry, H.; Hewala, I.; Emam, E. Development and Application of a Novel, Dual-Mode Gradient, Stability-Indicating HPLC-DAD Method for the Simultaneous Determination and Purity Assessment of Mebeverine Hydrochloride, Diloxanide Furoate and Their Corresponding Major Degradation Products in Combination with Some Gastrointestinal Drugs in the Form of Oral Doses. J. Pharm. Biomed. Anal. 2013, 83, 249–259. DOI: 10.1016/j.jpba.2013.04.013.
   PubMed Web of Science ®Google Scholar
• Schmidt, A.-H.; Molnár, I. Using an Innovative Quality-by-Design Approach for Development of a Stability Indicating UHPLC Method for Ebastine in the API and Pharmaceutical Formulations. J. Pharm. Biomed. Anal. 2013, 78–79, 65–74. DOI: 10.1016/j.jpba.2013.01.032.
   PubMed Web of Science ®Google Scholar
• Murthy, M.-V.; Krishnaiah, C.; Srinivas, K.; Rao, K.-S.; Kumar, N.-R.; Mukkanti, K. Development and Validation of RP-UPLC Method for the Determination of Darifenacin Hydrobromide, Its Related Compounds and Its Degradation Products Using Design of Experiments. J. Pharm. Biomed. Anal. 2013, 72, 40–50. DOI: 10.1016/j.jpba.2012.09.013.
   PubMed Web of Science ®Google Scholar
• Vemić, A.; Jančić Stojanović, B.; Stamenković, I.; Malenović, A. Chaotropic Agents in Liquid Chromatographic Method Development for the Simultaneous Analysis of Levodopa, Carbidopa, Entacapone and Their Impurities. J. Pharm. Biomed. Anal. 2013, 77, 9–15. DOI: 10.1016/j.jpba.2013.01.007.
   PubMed Web of Science ®Google Scholar
• van Wijk, A.-M.; Niederländer, H.-A.; Siebum, A.-H.; Vervaart, M.-A.; de Jong, G.-J. A New Derivatization Reagent for LC-MS/MS Screening of Potential Genotoxic Alkylation Compounds. J. Pharm. Biomed. Anal. 2013, 74, 133–140. DOI: 10.1016/j.jpba.2012.10.004.
   PubMed Web of Science ®Google Scholar
• Vijaya Bhaskar Reddy, A.; Venugopal, N.; Madhavi, G.; Gangadhara Reddy, K.; Madhavi, V. A Selective and Sensitive UPLC-MS/MS Approach for Trace Level Quantification of Four Potential Genotoxic Impurities in Zolmitriptan Drug Substance. J. Pharm. Biomed. Anal. 2013, 84, 84–89. DOI: 10.1016/j.jpba.2013.05.047.
   PubMedGoogle Scholar
• Locatelli, M.; De Lutiis, F.; Carlucci, G. High Performance Liquid Chromatography Determination of Prulifloxacin and Five Related Impurities in Pharmaceutical Formulations. J. Pharm. Biomed. Anal. 2013, 78–79, 27–33. DOI: 10.1016/j.jpba.2013.01.036.
   PubMed Web of Science ®Google Scholar
• CHROMacademy, Chapter 2, 3, 4 and 6, Reversed Phase Chromatogr. 1999, 3–18. http://www.chromacademy.com/lms/sco5/Theory-Of-HPLC-Reverse-Phase-Chromatography.pdf (accessed on 7 July, 2018)
   Google Scholar
• Dong, M.-W. Modern HPLC for Practicing Scientists; Wiley: Hoboken, 2006.
   Google Scholar
• Swartz, M. HPLC Detectors: A Brief Review. J. Liq. Chromatogr. Relat. Technol. 2010, 33, 1130–1150. DOI: 10.1080/10826076.2010.484356.
   Web of Science ®Google Scholar
• International Conference on Harmonisation, Q8 (R2): Pharmaceutical Development. ICH Harmonised Tripartite Guideline. 2009, 4, 1–24.
   Google Scholar
• Peraman, R.; Bhadraya, K.; Padmanabha Reddy, Y. Analytical Quality by Design: A Tool for Regulatory Flexibility and Robust Analytic. Int. J. Anal. Chem. 2015, 2015, 1–9. DOI: 10.1155/2015/868727.
   Google Scholar
• Ramachandra, B. Development of Impurity Profiling Methods Using Modern Analytical Techniques. Crit. Rev. Anal. Chem. 2017, 47, 24–36. DOI: 10.1080/10408347.2016.1169913.
   PubMed Web of Science ®Google Scholar